These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20368001)

  • 1. [Expression of survivin, caspase-3 in oral precancerous lesions and oral squamous-cell carcinoma].
    Ding YP; Li SX; Wu HR; Zhang XY; Tang XF; Sun Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):85-8. PubMed ID: 20368001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of survivin and caspase 3 in oral carcinogenesis.
    Poomsawat S; Punyasingh J; Vejchapipat P
    Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):65-71. PubMed ID: 23531848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
    Liu YM; Huang JH; Feng DY; Guo XC
    Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
    Palani J; Lakshminarayanan V; Kannan R
    Indian J Dent Res; 2011; 22(2):362. PubMed ID: 21891916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of survivin expression in leukoplakia, lichen planus, and oral squamous cell carcinoma: An immunohistochemical study.
    Angelin D; Nair BJ
    J Cancer Res Ther; 2020; 16(3):569-574. PubMed ID: 32719269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histochemical study of lectin receptor and cell morphometric analysis on oral leukoplakias, epithelial dysplasia and squamous carcinoma].
    Jiang Y; Wu Y; Wang F
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):351-3. PubMed ID: 9592290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells.
    Yan X; Su H
    Med Sci Monit; 2017 Apr; 23():1963-1972. PubMed ID: 28435150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma].
    Guo ZL; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.
    Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J
    J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of voltage-gated potassium channel Kv3.4 in oral squamous cell carcinoma].
    Wang R; Cai B; Xiang J; Zhu X; Jiang Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 Mar; 51(3):137-42. PubMed ID: 26980650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship?
    Lo Muzio L; Campisi G; Giovannelli L; Ammatuna P; Greco I; Staibano S; Pannone G; De Rosa G; Di Liberto C; D'Angelo M
    Oral Oncol; 2004 Aug; 40(7):736-41. PubMed ID: 15172644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin, a potential early predictor of tumor progression in the oral mucosa.
    Lo Muzio L; Pannone G; Leonardi R; Staibano S; Mignogna MD; De Rosa G; Kudo Y; Takata T; Altieri DC
    J Dent Res; 2003 Nov; 82(11):923-8. PubMed ID: 14578507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical study of benign lymphoadenosis of oral mucosa].
    Li SX; Yu SF; Sun KH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):410-3. PubMed ID: 15498351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of simple epithelial cytokeratin during oral carcinogenesis].
    Nie M; Li B; Zeng G; He Z; Chen Q; Zhou M; Luo G; Zeng X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Aug; 17(3):208-9, 220. PubMed ID: 12539284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia].
    Zhang J; Zeng Y; Zheng J; Xu J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):752-4. PubMed ID: 24495728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
    Routray S; Kheur SM; Kheur M
    Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.
    Piattelli A; Rubini C; Fioroni M; Iezzi G; Santinelli A
    J Oral Maxillofac Surg; 2002 May; 60(5):532-40. PubMed ID: 11988932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.